Prevalence and Prognostic Role of PIK3CA/AKT1 Mutations in Chinese Breast Cancer Patients
Ling Deng, Xuehua Zhu, Yun Sun, Jiemin Wang, Xiaorong Zhong, Jiayuan Li, Min Hu, Hong Zheng
Cancer Res Treat. 2019;51(1):128-140.   Published online 2018 Mar 15     DOI: https://doi.org/10.4143/crt.2017.598
Citations to this article as recorded by Crossref logo
Highly Sensitive Detection of PIK3CA Mutations by Looping-Out Probes-Based Melting Curve Analysis
Boheng Xu, Yanping Lan, Danjiao Luo, Yangsi Zheng, Runfang Ni, Guoqiang Su, Qiuying Huang, Qingge Li
Biochemical Genetics.2024; 62(1): 77.     CrossRef
Potential biomarkers in breast cancer drug development: application of the biomarker qualification evidentiary framework
Eric Wang, Mackenzie Henderson, Priyanka Yalamanchili, Jenilee Cueto, Zahidul Islam, Charles Dharmani, Maribel Salas
Biomarkers in Medicine.2024; : 1.     CrossRef
Analysis of PIK3CA Mutation Concordance and Frequency in Primary and Different Distant Metastatic Sites in Breast Cancer
Jieun Park, Soo Youn Cho, Eun Sol Chang, Minjung Sung, Ji-Young Song, Kyungsoo Jung, Sung-Su Kim, Young Kee Shin, Yoon-La Choi
Cancer Research and Treatment.2023; 55(1): 145.     CrossRef
Computational pathology to improve biomarker testing in breast cancer: how close are we?
Elham Sajjadi, Chiara Frascarelli, Konstantinos Venetis, Giuseppina Bonizzi, Mariia Ivanova, Gianluca Vago, Elena Guerini-Rocco, Nicola Fusco
European Journal of Cancer Prevention.2023; 32(5): 460.     CrossRef
Clinicopathologic and Genomic Features in Triple-Negative Breast Cancer Between Special and No-Special Morphologic Pattern
Ying-Zi Li, Bo Chen, Xiao-Yi Lin, Guo-Chun Zhang, Jian-Guo Lai, Cheukfai Li, Jia-Li Lin, Li-Ping Guo, Wei-Kai Xiao, Hsiaopei Mok, Chong-Yang Ren, Ling-Zhu Wen, Fang-Rong Cao, Xin Lin, Xiao-Fang Qi, Yang Liu, Ning Liao
Frontiers in Oncology.2022;[Epub]     CrossRef
PIK3CA Mutation as Potential Poor Prognostic Marker in Asian Female Breast Cancer Patients Who Received Adjuvant Chemotherapy
Yoon Ah Cho, Seung Yeon Ko, Yong Joon Suh, Sanghwa Kim, Jung Ho Park, Hye-Rim Park, Jinwon Seo, Hyo Geun Choi, Ho Suk Kang, Hyun Lim, Ha Young Park, Mi Jung Kwon
Current Oncology.2022; 29(5): 2895.     CrossRef
Using an Improved Residual Network to Identify PIK3CA Mutation Status in Breast Cancer on Ultrasound Image
Wen-Qian Shen, Yanhui Guo, Wan-Er Ru, Cheukfai Li, Guo-Chun Zhang, Ning Liao, Guo-Qing Du
Frontiers in Oncology.2022;[Epub]     CrossRef
Expert consensus on the clinical application of PI3K/AKT/mTOR inhibitors in the treatment of advanced breast cancer
Cancer Innovation.2022; 1(1): 25.     CrossRef
Clinicopathological characteristics and prognostic analysis of PIK3CA mutation in breast cancer patients in Northwest China
Wei Lv, Chong Du, Yinbing Zhang, Fei Wu, Yaofeng Jin, Xi Chen, Xuan Liu, Cong Feng, Xingcong Ma, Shuqun Zhang
Pathology - Research and Practice.2022; 238: 154063.     CrossRef
Comparison of PIK3CA Mutation Prevalence in Breast Cancer Across Predicted Ancestry Populations
Jessica W. Chen, Karthikeyan Murugesan, Justin Y. Newberg, Ethan S. Sokol, Heidi M. Savage, Thomas J. Stout, Sophia L. Maund, Katherine E. Hutchinson
JCO Precision Oncology.2022;[Epub]     CrossRef
PIK3CA-mutated breast cancer: from research to clinical practice
A. L. Kornietskaya, L. V. Bolotina, S. F. Evdokimova, V. V. Savchina, Yu. B. Karagodina, A. A. Kachmazov
Meditsinskiy sovet = Medical Council.2022; (22): 148.     CrossRef
The Correlation of Mutations and Expressions of Genes within the PI3K/Akt/mTOR Pathway in Breast Cancer—A Preliminary Study
Przemysław Kołodziej, Marcin Nicoś, Paweł A. Krawczyk, Jacek Bogucki, Agnieszka Karczmarczyk, Daniel Zalewski, Tomasz Kubrak, Elżbieta Kołodziej, Anna Makuch-Kocka, Barbara Madej-Czerwonka, Bartosz J. Płachno, Janusz Kocki, Anna Bogucka-Kocka
International Journal of Molecular Sciences.2021; 22(4): 2061.     CrossRef
Anticancer drug discovery from Iranian Chrysanthemum cultivars through system pharmacology exploration and experimental validation
Mahboobeh Hodaei, Mehdi Rahimmalek, Mandana Behbahani
Scientific Reports.2021;[Epub]     CrossRef
Cell-free DNA comparative analysis of the genomic landscape of first-line hormone receptor-positive metastatic breast cancer from the US and China
Xiaoran Liu, Andrew A. Davis, Feng Xie, Xinyu Gui, Yifei Chen, Qiang Zhang, Lorenzo Gerratana, Youbin Zhang, Ami N. Shah, Amir Behdad, Firas Wehbe, Yong Huang, Jianjun Yu, Pan Du, Shidong Jia, Huiping Li, Massimo Cristofanilli
Breast Cancer Research and Treatment.2021; 190(2): 213.     CrossRef
Network Pharmacology-Based Dissection of the Comprehensive Molecular Mechanisms of the Herbal Prescription FDY003 Against Estrogen Receptor-Positive Breast Cancer
Ho-Sung Lee, In-Hee Lee, Kyungrae Kang, Sang-In Park, Minho Jung, Seung Gu Yang, Tae-Wook Kwon, Dae-Yeon Lee
Natural Product Communications.2021; 16(9): 1934578X2110443.     CrossRef
Clinical significance of gene polymorphisms for hereditary predisposition to breast and ovarian cancer (review of literature)
D. I. Vodolazhsky, A. V. Mayakovskaya, A. V. Kubyshkin, K. A. Aliev, I. I. Fomochkina
Russian Clinical Laboratory Diagnostics.2021; 66(12): 760.     CrossRef
Real world data analysis of next generation sequencing and protein expression in metastatic breast cancer patients
Dirk Hempel, Florian Ebner, Arun Garg, Zeljka Trepotec, Armin Both, Werner Stein, Andreas Gaumann, Lucia Güttler, Wolfgang Janni, Amelie DeGregorio, Louisa Hempel, Valeria Milani
Scientific Reports.2020;[Epub]     CrossRef
PIK3CA H1047R Mutation Associated with a Lower Pathological Complete Response Rate in Triple-Negative Breast Cancer Patients Treated with Anthracycline-Taxane–Based Neoadjuvant Chemotherapy
Sanxing Guo, Sibylle Loibl, Gunter von Minckwitz, Silvia Darb-Esfahani, Bianca Lederer, Carsten Denkert
Cancer Research and Treatment.2020; 52(3): 689.     CrossRef
Clinical-Pathologic Analysis of Breast Cancer With PIK3CA Mutations in Chinese Women
Jing Lian, En-Wei Xu, Yan-Feng Xi, Hui-Wen Wang, Peng Bu, Jin-fen Wang, Li-Xia Wang
Technology in Cancer Research & Treatment.2020; 19: 153303382095083.     CrossRef
PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects
Daniela Miricescu, Alexandra Totan, Iulia-Ioana Stanescu-Spinu, Silviu Constantin Badoiu, Constantin Stefani, Maria Greabu
International Journal of Molecular Sciences.2020; 22(1): 173.     CrossRef
Transcriptomic analysis associated with reversal of cisplatin sensitivity in drug resistant osteosarcoma cells after a drug holiday
Divya Niveditha, Harshita Sharma, Syamantak Majumder, Sudeshna Mukherjee, Rajdeep Chowdhury, Shibasish Chowdhury
BMC Cancer.2019;[Epub]     CrossRef
PIK3CA Gene Mutations in Solid Malignancies: Association with Clinicopathological Parameters and Prognosis
Ali Alqahtani, Hazem S. K. Ayesh, Hafez Halawani
Cancers.2019; 12(1): 93.     CrossRef